These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 27158095)

  • 1. Microbiome therapeutics - Advances and challenges.
    Mimee M; Citorik RJ; Lu TK
    Adv Drug Deliv Rev; 2016 Oct; 105(Pt A):44-54. PubMed ID: 27158095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering commensal bacteria to rewire host-microbiome interactions.
    Hwang IY; Chang MW
    Curr Opin Biotechnol; 2020 Apr; 62():116-122. PubMed ID: 31654857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome-based therapeutics: Opportunity and challenges.
    Pant A; Das B
    Prog Mol Biol Transl Sci; 2022; 191(1):229-262. PubMed ID: 36270680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic engineering of human gut microbiome: Recent developments and future perspectives.
    Li P; Roos S; Luo H; Ji B; Nielsen J
    Metab Eng; 2023 Sep; 79():1-13. PubMed ID: 37364774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress.
    Lim YY; Lee YS; Ooi DSQ
    Biotechnol J; 2020 Oct; 15(10):e2000013. PubMed ID: 32663372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Age of Next-Generation Therapeutic-Microbe Discovery: Exploiting Microbe-Microbe and Host-Microbe Interactions for Disease Prevention.
    Cruz N; Abernathy GA; Dichosa AEK; Kumar A
    Infect Immun; 2022 May; 90(5):e0058921. PubMed ID: 35384688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.
    Ozdemir T; Fedorec AJH; Danino T; Barnes CP
    Cell Syst; 2018 Jul; 7(1):5-16. PubMed ID: 30048620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation probiotics: Engineering live biotherapeutics.
    Murali SK; Mansell TJ
    Biotechnol Adv; 2024; 72():108336. PubMed ID: 38432422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mining the Microbiome and Microbiota-Derived Molecules in Inflammatory Bowel Disease.
    Bekkers M; Stojkovic B; Kaiko GE
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial community in human gut: a therapeutic prospect and implication in health and diseases.
    Dwivedi M; Powali S; Rastogi S; Singh A; Gupta DK
    Lett Appl Microbiol; 2021 Nov; 73(5):553-568. PubMed ID: 34365651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the microbiome in human health and disease: an introduction for clinicians.
    Young VB
    BMJ; 2017 Mar; 356():j831. PubMed ID: 28298355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Microbiome: What Will the Future Hold?
    Monsour HP; Quigley EM
    Semin Liver Dis; 2016 Sep; 36(4):354-359. PubMed ID: 27997976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment.
    Huang Y; Lin X; Yu S; Chen R; Chen W
    ACS Synth Biol; 2022 Oct; 11(10):3134-3153. PubMed ID: 36094344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics.
    Porcari S; Fusco W; Spivak I; Fiorani M; Gasbarrini A; Elinav E; Cammarota G; Ianiro G
    Lancet Gastroenterol Hepatol; 2024 May; 9(5):460-475. PubMed ID: 38604200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
    Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Our Microbiome: On the Challenges, Promises, and Hype.
    Federici S; Suez J; Elinav E
    Results Probl Cell Differ; 2020; 69():539-557. PubMed ID: 33263886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing the microbiota for therapeutic purposes.
    Liwinski T; Elinav E
    Am J Transplant; 2020 Jun; 20(6):1482-1488. PubMed ID: 31858698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiome therapeutics for hepatic encephalopathy.
    Bloom PP; Tapper EB; Young VB; Lok AS
    J Hepatol; 2021 Dec; 75(6):1452-1464. PubMed ID: 34453966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered Live Biotherapeutics: Progress and Challenges.
    Tan Y; Shen J; Si T; Ho CL; Li Y; Dai L
    Biotechnol J; 2020 Oct; 15(10):e2000155. PubMed ID: 32770635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.